安徽宏宇五洲医疗器械股份有限公司 2025年度业绩预告

Group 1 - The company expects a significant decline in net profit, projecting a decrease of over 50% for the fiscal year 2025 [1] - The performance forecast period is from January 1, 2025, to December 31, 2025, with net profit anticipated to be positive but substantially lower than the previous year [1] - The company has communicated with its accounting firm regarding the performance forecast, and there are no discrepancies noted, pending the final audit results [1] Group 2 - The decline in revenue is attributed to increased market competition and changes in market demand, which have also led to a decrease in product prices [1] - Financial expenses have increased significantly year-on-year, primarily due to foreign exchange losses resulting from currency fluctuations, further impacting profit levels [1]